Sigma Pharmaceutical Limited  

(Public, ASX:SIP)   Watch this stock  
Find more results for SIP
-0.005 (-0.61%)
Aug 22 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.81 - 0.82
52 week 0.50 - 0.83
Open 0.82
Vol / Avg. 977,999.00/1.49M
Mkt cap 892.08M
P/E 16.61
Div/yield 0.02/4.91
EPS 0.05
Shares 1.12B
Beta     -
Inst. own     -
Sep 11, 2014
Interim 2014 SIGMA PHARMACEUTICALS LTD Earnings Release Add to calendar

Key stats and ratios

Q1 (Jan '14) 2014
Net profit margin 2.47% 1.80%
Operating margin 3.01% 2.36%
EBITD margin - 2.35%
Return on average assets 7.31% 5.35%
Return on average equity 12.90% 9.00%
Employees 156 -
CDP Score - -


3 Myer Place, Rowville
, VIC 3178
+61-3-92159215 (Phone)
+61-3-92159188 (Fax)

Website links


Sigma Pharmaceuticals Limited is engaged in the marketing and wholesale distribution of pharmaceutical products through the pharmacy and grocery sales channels and the provision of services to retail pharmacists. The Company�s brands include Amcal Max, Amcal and Guardian. The Company�s Amcal Max Health Management Services offering professional advice and products across various key categories including heart health, bones and joints, diabetes and respiration.

Officers and directors

Mark Hooper Chief Executive Officer, Managing Director, Executive Director
Jeffrey Sells Chief Financial Officer
Gary Dunne Chief Operating Officer
Susan Morgan-Dethick General Counsel, Company Secretary
Richard Church General Manager - Logistics
Richard Harris General Manager - Systems & Information Technology
Alan O'Hara General Manager - Supply Chain and Transformation
Claire Pallot General Manager - Multi Channel
Michael Robertson General Manager - Retail Operations
Vincent Gualtieri General Manager - Wholesale Sales